Your browser doesn't support javascript.
loading
An LC/MS based method to quantify DNA adduct in tumor and organ tissues.
Li, Chao; Dong, Linlin; Kamali, Afrand; Sugimoto, Hiroshi; Abdul-Hadi, Kojo; Chen, Susan; Abu-Yousif, Adnan; Qian, Mark G.
Affiliation
  • Li C; Department of Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International, Inc., 35 Landsdowne Street, Cambridge, MA, 02139, USA.
  • Dong L; Department of Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International, Inc., 35 Landsdowne Street, Cambridge, MA, 02139, USA.
  • Kamali A; Department of Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International, Inc., 35 Landsdowne Street, Cambridge, MA, 02139, USA.
  • Sugimoto H; Department of Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International, Inc., 35 Landsdowne Street, Cambridge, MA, 02139, USA.
  • Abdul-Hadi K; Department of Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International, Inc., 35 Landsdowne Street, Cambridge, MA, 02139, USA.
  • Chen S; Department of Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International, Inc., 35 Landsdowne Street, Cambridge, MA, 02139, USA.
  • Abu-Yousif A; Department of Immunology-Oncology Research, Takeda Pharmaceuticals International, Inc., 40 Landsdowne Street, Cambridge, MA, 02139, USA.
  • Qian MG; Department of Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International, Inc., 35 Landsdowne Street, Cambridge, MA, 02139, USA. Electronic address: mark.qian@takeda.com.
Anal Biochem ; 568: 1-6, 2019 03 01.
Article in En | MEDLINE | ID: mdl-30579655
ABSTRACT
Highly potent DNA damaging agents have become a key class of toxins for antibody-drug conjugate (ADC) based targeted therapy. However, until recently, no quantitative bioanalytical method was available to measure the toxin in the form of DNA adducts. In this work, a novel microwave assisted organic solvent extraction and LC-MS/MS based bioanalytical method was developed to extract and quantify DNA-bound toxin IGN-P1 in tissue samples. Using ADC-1 as the model ADC, the method was orthogonally checked with a radioactive method for the recovery of free toxins from DNA adducts in biological matrices. It was found that the bioanalytical method can achieve a high recovery of the IGN-P1 toxin from DNA adducts. In further assessment, tumor and organ tissue samples collected at multiple time points from in vivo studies after dosing with two other ADCs, ADC-2 and ADC-3, were measured by the method. Given the generic nature of the established bioanalytical method without the need of radiolabels, the methodology could be broadly utilized to quantitatively assess the relationship between DNA adduct levels and pharmacological/toxicological effects.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Spleen / Benzodiazepines / Immunoconjugates / DNA Adducts / Liver Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals / Humans Language: En Year: 2019 Type: Article

Full text: 1 Database: MEDLINE Main subject: Spleen / Benzodiazepines / Immunoconjugates / DNA Adducts / Liver Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals / Humans Language: En Year: 2019 Type: Article